Shift from protocol-based to personalized medicine in active surveillance: beginning of a new era
BJU Int
.
2017 Jul;120(1):3-4.
doi: 10.1111/bju.13677.
Author
Stacy Loeb
1
Affiliation
1
Department of Urology, Population Health, Laura & Isaac Perlmutter Cancer Center, New York University, New York, NY, USA.
PMID:
28621058
DOI:
10.1111/bju.13677
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Humans
Precision Medicine*
Grants and funding
K07 CA178258/CA/NCI NIH HHS/United States